Injectafer
Sponsors
American Regent, Inc., United States Army Research Institute of Environmental Medicine
Conditions
Cancer and Chemotherapy Related AnemiaFibromyalgiaHypoxiaIron DeficiencyIron Deficiency Anemia (IDA)Iron Deficiency Anemia Secondary to IBD or Gastric BypassRestless Legs Syndrome (RLS)
Phase 2
Phase 3
Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS
CompletedNCT02397057
Start: 2015-01-31End: 2018-01-31Updated: 2021-10-12
Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®
CompletedNCT02453334
Start: 2015-05-23End: 2018-01-04Updated: 2021-05-11
Phase 4
Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron
CompletedNCT01950247
Start: 2013-08-15End: 2015-06-30Updated: 2025-05-22
Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass
CompletedNCT02086968
Start: 2014-01-01End: 2017-10-31Updated: 2020-09-17
Intravenous Iron Effects on Performance at High Altitude
RecruitingNCT06686693
Start: 2022-04-15End: 2025-09-30Target: 24Updated: 2025-03-30